Company news
Akanda Corp. (NASDAQ:AKAN) news
Akanda Corp. news releases on 6ix. Latest, Feb 20, 2024: Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders
Press releases — page 2
Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders
February 19, 2024
Akanda Corp. Discusses Positive Trends in UK Cannabis Market
February 12, 2024
Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval
February 1, 2024
Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 1, 2024
Akanda Corp. Entered into Non-Binding Letter of Intent for Sale of RPK
January 31, 2024
Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
January 3, 2024
Akanda Corporation Announces CFO Appointment
December 10, 2023
Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility
September 19, 2023
Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 5, 2023
Akanda Corp. Announces Termination of Loan Agreement
May 28, 2023
Akanda Corp. Announces Loan Agreement
April 27, 2023
Akanda Corporation Has Regained Compliance with NASDAQ’s Minimum Bid Price Requirement
March 28, 2023
Akanda Corporation Announces 1-for-10 Reverse Stock Split
March 7, 2023
Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director
February 15, 2023
Akanda Corp.’s Chief Executive Officer Submits Resignation
February 6, 2023
Akanda Books €1.8M of Revenue in Q4 2022 As German Sales Start
February 1, 2023
Akanda Corp.’s Chief Executive Officer On Paid Leave of Absence
December 20, 2022
Akanda Targets 10% of German Medical Cannabis Market with its Premium Flower Cultivation Operations in Portugal
November 15, 2022
Akanda Announces Arrival of First Shipment and Sales of Medical Cannabis to Germany
November 7, 2022
Akanda Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position
September 25, 2022
Akanda Partners with Cookies to Bring the Iconic Cannabis Brand and High THC Strains to European Consumers for the First Time
September 12, 2022
Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe
August 23, 2022
Akanda to Supply Cansativa with Premium Indoor Cannabis Flower Grown at its Sintra Facility in Portugal
August 8, 2022
Akanda to Contest Unauthorized Liquidation of its Lesotho-Based Subsidiary, Bophelo Bio Science & Wellness (Pty) Ltd.
July 25, 2022
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
July 11, 2022
Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)
May 1, 2022
Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access
April 19, 2022
Akanda Corp. Closes Initial Public Offering
March 16, 2022
Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market
March 14, 2022
Akanda Corp. Announces Pricing of Initial Public Offering and Expects To Commence Trading on NASDAQ Tomorrow
March 13, 2022